Johns Hopkins Researchers Develop Test to ID Aggressive Ovarian Cancers Early | Naviance

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the translatepress-multilingual domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/gonaviance/public_html/wp-includes/functions.php on line 6114

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/gonaviance/public_html/wp-includes/functions.php on line 6114
Johns Hopkins Researchers Develop Test to ID Aggressive Ovarian Cancers Early | Naviance

Investigadores de Johns Hopkins desarrollan una prueba para identificar tempranamente los cánceres de ovario agresivos

Johns Hopkins Researchers Develop Test to ID Aggressive Ovarian Cancers Early

Investigadoras en el Centro Oncológico Johns Hopkins Kimmel y el Departamento de Ginecología y Obstetricia del Johns Hopkins University School of Medicine han desarrollado un algoritmo para identificar lesiones precancerosas de alto riesgo en las trompas de Falopio.

LEER AQUÍ

VER TODAS LAS NOTICIAS

Mensajes recientes

Study Suggests a Healthy Diet May Help Keep Low Grade Prostate Cancer From Progressing to More Dangerous States During Active Surveillance Experimental Cancer Drug Eliminates Bone Metastases Caused by Breast Cancer in Lab Models Johns Hopkins Joins Cancer AI Alliance AI ‘Liquid Biopsies’ Using Cell-Free DNA, Protein Biomarkers, Could Aid Early Detection of Ovarian Cancer A Common Culprit Drives Prostate Cancer Progression Immunotherapy Before and After Lung Cancer Surgery Reduces Death Risk, Disease Recurrence Age-Related Changes in Male Fibroblasts Increase Treatment-Resistant Melanoma Scientists Identify Potential New Immune System Target to Head Off the Spread of Breast Cancer Cells Johns Hopkins Researchers Identify Key Markers in Pancreatic Cancer Progression Using a New Analysis Pipeline